CClinicalTrials.gg
Not yet recruitingNCT05959642Updated Jul 27, 2023

Comparing Controlled Flow Delivery Dentapen® Technique to Traditional Syringes

An interventional study of dentapen and Traditional metal Syringes in Early Childhood Caries, sponsored by Cairo University. Not yet recruiting. Open to participants aged 6 Years to 8 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-07-27.

Sponsored by Cairo University · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Oct 2024, 1 year 11 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
6 Years to 8 Years
Sex
All
01

Study summary

This study compares the effect of the controlled flow delivery Dentapen® technique to traditional syringes on pain perception during dental procedures among a group of pediatric dental patients

Read the detailed description

Local anesthetic injections are usually the main reason for fear and anxiety during dental treatment. Pain management is a critical aspect of pediatric dental care. Fear associated with seeing and experiencing needle penetration, sensation of swelling soft tissues and prolonged numbness as well as allergic reactions to the anesthetic fluid, are the most common factors causing patients and dental clinicians to experience anxiety regarding the use of infiltration local anesthesia. Exploring new alternative and a traumatic method will help improving the quality of care in pediatric dentistry.

Consequently, there is a constant search for new techniques looking to avoid the invasive and often painful nature of the anaesthetic injection required for dental treatments, making it a more pleasant and less distressing experience for patients.

Even though there are no techniques available that can totally replace conventional local anaesthesia, some alternatives have been developed that are effective in a limited range of procedures. In 1997, a new method for the administration of anaesthetics was launched: the computer- controlled local anaesthesia delivery system (CCLADS). After

2006, the single tooth anaesthesia system (STA) (Milestone Scientific, Inc. Livingston, NJ, USA) was also introduced.

Currently, one of the most discouraging aspects for many patients undergoing dental procedures is the administration of anaesthesia. Consequently, there is a constant search for new techniques to avoid the invasive and painful nature of the injection. A new, cableless, motorised syringe system (Dentapen®) has recently been developed, standing out for its convenience and ease of use. The slow injection of anaesthetics at low pressure appears to reduce pain and discomfort during dental anaesthesia, and that currently does not require specific training. It has several injection settings, allowing it to be held like a syringe or pen, and is compatible with all anaesthetic needles and cartridges from all brands with an accurate control of flow and pressure of the injection can therefore mitigate the pain experienced by these patients.

So, the purpose of the current study was to evaluate the effect of controlled flow delivery Dentapen® technique on pain perception among a group of pediatric dental patients in comparison to conventional injection technique.

02

Conditions studied

  • Early Childhood Caries

Keywords

  • non invasive technique
03

In context

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 8 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Children aged between 6 and 8 years

    • Healthy children with no systemic problems.
    • Cooperative Children
    • First dental visit
    • Children willing to provide assent and parent willing to provide informed consent
    • Bilaterally decayed primary maxillary first molars with normal radiographic findings and need restorative treatment

Exclusion criteria

Exclusion Criteria:

Children with previously restored teeth

  • Children requiring emergency dental treatment (cellulitis, abscess)
  • Children's teeth with signs or symptoms of Pulpitis
  • Children whose parents refuse to sign the informed consent.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Controlled Flow Delivery Dentapen

    Controlled Flow Delivery Dentapen - infiltration upper d according to the manufacturer instructions it works with standardised 1.8 ml local anaesthetic carpules . 1)we raise the lip a little 2) we use dentapen for anaesthesia 3) class 1 cavity preparation Articaine hydrochloride 4% with 1:100,000 epinephrine will be injected.The dentist will wait 5 seconds

    Device: dentapen

  • Active comparator
    Traditional metal Syringes

    Traditional metal Syringes we raise the lip a little 2) infiltration upper d we use traditional syringes 3)class 1 cavity preparation with composit filling works with standardised 1.8 ml local anaesthetic carpules . we use Articaine hydrochloride 4% with 1:100,000 epinephrine will be injected.The dentist will wait 5 seconds

    Device: Traditional metal Syringes

Interventions

  • Devicedentapen

    Experimental: Controlled Flow Delivery Dentapen according to the manufacturer instructions, It works with standardised 1.8 mL local anaesthetic carpules. The distalingual and mesiolingual line angles are the most effective for multi-rooted upper D teeth. Articaine hydrochloride 4% with 1:100,000 epinephrine will be injected for each root as shown on a special indicator.The dentist will wait 5 seconds before needle withdrawal. Same steps will be repeated at the mesiolingual line angle

  • DeviceTraditional metal Syringes

    Active Comparator: Conventional Injection of infiltration upper d a standard technique for the Injection of infiltration upper d will be used supplemented with long buccal infiltration for the buccal gingiva. A 27-gauge disposable dental needle will be used to inject Articaine hydrochloride 4% with 1:100,000 epinephrine. The needle will be directed to primary molars

06

What researchers measure

Primary outcomes

  1. Pain perception during injection of local anesthesia

    Wong-Baker faces pain rating scale; Scores (0-10)

    Time frame: in the same visit after finishing the procedure, 0 scale - no pain , 10 scale -worest

Secondary outcomes

  1. Heart rate during injection of local anesthesia

    measured by Pulse oximeter, Beats per minute (BPM)

    Time frame: in the same visit after finishing the procedure

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Carvajal-Nunez U, Prieur D, Vitova T, Somers J. Charge distribution and local structure of americium-bearing thorium oxide solid solutions. Inorg Chem. 2012 Nov 5;51(21):11762-8. doi: 10.1021/ic301709d. Epub 2012 Oct 16. PubMed 23072315 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 27, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05959642
Lead sponsor
Cairo University
Responsible party
reham salman alshakhs (Master Degree Student, Cairo University) — Principal investigator
First posted
Jul 25, 2023
Start date
Jan 1, 2024 (estimated)
Primary completion
Oct 30, 2024 (estimated)
Completion
Dec 1, 2024 (estimated)
Last update
Jul 27, 2023

Study contacts

Reham Salman Alshakhs
Contact
rehamsalman23@gmail.com
00966599928825 ext. 0
Prof. Dr. Sherif Salman Bahgat
Contact
rehamsalman23@gmail.com
00966599928823 ext. 0

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion